Cargando…
Delivery of adoptive cell therapy in the context of the health-care system in the UK: challenges for clinical sites
Advanced Therapy Medicinal Products (ATMPs) comprise novel cell, tissue and gene therapies and offer the potential of durable remissions for diseases where there is a high unmet clinical need. Once considered a niche area of academic research, ATMPs now represent one of the fastest-growing areas of...
Autores principales: | Pillai, Manon, Davies, Michelle M., Thistlethwaite, Fiona C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509731/ https://www.ncbi.nlm.nih.gov/pubmed/33015538 http://dx.doi.org/10.1177/2515135520944355 |
Ejemplares similares
-
Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies
por: Shohdy, Kyrillus S., et al.
Publicado: (2023) -
Challenges and new technologies in adoptive cell therapy
por: Zhang, Pengchao, et al.
Publicado: (2023) -
Social Context and Hearing Aid Adoption
por: Singh, Gurjit, et al.
Publicado: (2016) -
Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens
por: Jæhger, Ditte E., et al.
Publicado: (2021) -
An overview of nuclear medicine research in the UK and the landscape for clinical adoption
por: Young, Jennifer D., et al.
Publicado: (2021)